Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in U.S. thousands)
| 09-2025 | 09-2024 | 09-2023 | 09-2022 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 256,492 | 264,316 | 201,644 | 183,898 | 317,823 |
| Depreciation Amortization | 98,597 | 84,408 | 94,654 | 105,049 | 114,130 |
| Income taxes - deferred | 4,988 | -21,612 | -18,337 | -29,465 | -37,048 |
| Accounts receivable | -18,463 | -28,967 | 47,779 | -14,314 | -49,034 |
| Other Working Capital | -17,012 | -118,711 | -47,084 | -56,254 | -24,638 |
| Other Operating Activity | 147,596 | 147,818 | 88,425 | 129,662 | 126,520 |
| Operating Cash Flow | $472,198 | $327,252 | $367,081 | $318,576 | $447,753 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,911 | 73,863 | -117,991 | -301,854 | N/A |
| PPE Investments | -36,348 | -30,007 | -30,339 | -47,928 | -38,089 |
| Net Acquisitions | -1,362 | -487,877 | 25,703 | -38,171 | -4,500 |
| Purchase Of Investment | -75 | N/A | N/A | -5,000 | -67,101 |
| Sale Of Investment | 0 | 157,729 | 176,833 | 108,546 | 64,785 |
| Purchase Sale Intangibles | -5,593 | N/A | N/A | -11,528 | N/A |
| Other Investing Activity | 11,288 | 0 | 0 | -11,528 | 0 |
| Investing Cash Flow | $-10,586 | $-286,292 | $54,206 | $-295,935 | $-44,905 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 43,697 | 40,203 | 47,781 | 57,848 | 122,088 |
| Common Stock Repurchased | -125,253 | -160,001 | -149,276 | -530,486 | -245,864 |
| Dividend Paid | -126,599 | -114,579 | -103,407 | -100,067 | -89,172 |
| Other Financing Activity | -39,083 | -53,437 | -31,910 | -37,853 | -39,567 |
| Financing Cash Flow | $-247,238 | $-287,814 | $-236,812 | $-610,558 | $-252,515 |
| Exchange Rate Effect | 1,235 | 6,640 | 5,120 | -16,744 | 2,720 |
| Beginning Cash Position | 577,752 | 817,966 | 628,371 | 1,233,032 | 1,079,979 |
| End Cash Position | 793,361 | 577,752 | 817,966 | 628,371 | 1,233,032 |
| Net Cash Flow | $215,609 | $-240,214 | $189,595 | $-604,661 | $153,053 |
| Free Cash Flow | |||||
| Operating Cash Flow | 472,198 | 327,252 | 367,081 | 318,576 | 447,753 |
| Capital Expenditure | -36,348 | -30,007 | -30,339 | -47,928 | -54,454 |
| Free Cash Flow | 435,850 | 297,245 | 336,742 | 270,648 | 393,299 |